Nucleic Acids Research

Nucleic Acids Research 2005 33(19):6151-6163; doi:10.1093/nar/gki930

This Article Abstract Print PDF (1077K) Screen PDF (406K) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Commercial Re-use Guidelines for Open Access NAR Content Google Scholar Articles by Silverman, S. K. Search for Related Content PubMed PubMed Citation Articles by Silverman, S. K. Social Bookmarking          What's this?

Published online 11 November 2005

© The Author 2005. Published by Oxford University Press. All rights reserved
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions{at}oxfordjournals.org

Survey and Summary

In vitro selection, characterization, and application of deoxyribozymes that cleave RNA

Scott K. Silverman^*

Department of Chemistry, University of Illinois at Urbana-Champaign 600 South Mathews Avenue, Urbana, IL 61801, USA

^*To whom correspondence should be addressed. Tel: +1 217 244 4489; Fax: +1 217 244 8024; Email: scott{at}scs.uiuc.edu

Received September 20, 2005. Revised October 10, 2005. Accepted October 10, 2005.

	ABSTRACT

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
Over the last decade, many catalytically active DNA molecules (deoxyribozymes; DNA enzymes) have been identified by in vitro selection from random-sequence DNA pools. This article focuses on deoxyribozymes that cleave RNA substrates. The first DNA enzyme was reported in 1994 and cleaves an RNA linkage. Since that time, many other RNA-cleaving deoxyribozymes have been identified. Most but not all of these deoxyribozymes require a divalent metal ion cofactor such as Mg²⁺ to catalyze attack by a specific RNA 2'-hydroxyl group on the adjacent phosphodiester linkage, forming a 2',3'-cyclic phosphate and a 5'-hydroxyl group. Several deoxyribozymes that cleave RNA have utility for in vitro RNA biochemistry. Some DNA enzymes have been applied in vivo to degrade mRNAs, and others have been engineered into sensors. The practical impact of RNA-cleaving deoxyribozymes should continue to increase as additional applications are developed.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
Deoxyribozymes are DNA molecules with catalytic activity. Their RNA analogues, ribozymes, participate in fundamental reactions of modern biochemistry such as viral RNA self-processing (1), RNA splicing (2,3), and translation of RNA into protein (4,5). Ribozymes are widely hypothesized to have both carried information and performed catalysis during the primordial ‘RNA World’ (6,7). Unlike ribozymes, deoxyribozymes are not known to exist naturally. For either RNA or DNA, our chemical understanding is insufficient to allow prediction of a specific nucleotide sequence that will catalyze a desired reaction. Despite this lack of predictive ability (and, for DNA, without any clues from nature), artificial ribozymes and deoxyribozymes can readily be identified through in vitro selection (8,9). In this approach, large random-sequence ‘pools’ of nucleic acids are iteratively examined until a small number of catalytically active sequences are obtained (10,11). These nucleic acid enzymes can be studied to determine their catalytic abilities, structures and mechanisms. In some cases, they can also be used for practical applications.

The known natural ribozymes all function with nucleic acid substrates, with the important exception of the ribosome that creates peptide bonds (1). In contrast, artificial ribozymes identified by in vitro selection catalyze a growing variety of chemical reactions (12–18). For deoxyribozymes, the substrates have almost always been nucleic acids themselves [with a few exceptions; (19,20)], and a number of recent reviews have addressed the scope of DNA's catalytic activity using such substrates (21–25). This article focuses specifically on deoxyribozymes that cleave RNA. Deoxyribozymes have also been termed DNA enzymes or catalytic DNA, and these terms are used interchangeably here. The contraction ‘DNAzyme’ will generally be avoided.

The first reported DNA enzyme was described by Breaker and Joyce (26) in December 1994 and cleaves a specific RNA linkage embedded within a longer nucleic acid strand. Many RNA-cleaving deoxyribozymes have been identified in the intervening decade (27–36). Some of these DNA enzymes have excellent catalytic rates, turnover numbers and abilities to cleave a wide range of RNA substrate sequences, and their practical utility has been exploited in several ways. The following sections describe how RNA-cleaving deoxyribozymes have been identified, characterized and applied in biochemistry and other areas.

	IN VITRO SELECTION OF DEOXYRIBOZYMES THAT CLEAVE RNA, PART 1: THE FIRST EXPERIMENTS

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
All known RNA-cleaving deoxyribozymes catalyze the chemically identical cleavage reaction: attack of an RNA 2'-hydroxyl group on the adjacent phosphodiester linkage, which forms 2',3'-cyclic phosphate and 5'-hydroxyl RNA termini (Figure 1). This intramolecular cleavage reaction is also catalyzed by many protein ribonucleases such as RNase A, and the cleavage mechanism has been widely studied both in proteins and in small model systems (37). Formation of an RNA 2',3'-cyclic phosphate via intramolecular cleavage is facile even without catalysis; e.g. simply incubating an RNA strand under basic conditions leads to random scission along the entire length of the strand (38,39). Therefore, DNA does not have to work particularly hard to increase the rate of an already-favorable reaction. Nevertheless, the extremely high selectivity with which deoxyribozymes have been shown to cleave RNA substrates at particular locations is intriguing and useful.

View larger version (13K): [in this window] [in a new window]   Figure 1 RNA cleavage with formation of 2',3'-cyclic phosphate and 5'-hydroxyl termini. This reaction can occur alone or with a catalyst such as a protein enzyme, ribozyme or deoxyribozyme. In most but not all cases, a divalent metal ion cofactor (M2+) is required to achieve an appreciable reaction rate.

 
In the earliest effort to identify catalytic DNA (26), five iterated selection rounds were used to identify a Pb²⁺-dependent deoxyribozyme that cleaves RNA according to the reaction of Figure 1. The selection strategy used a nucleic acid substrate made entirely from DNA except with a single embedded ribonucleotide linkage, which directed cleavage to the sole RNA junction within the strand (Figure 2, strategy 1). For brevity, the substrate is termed here ‘the RNA substrate’, although only one linkage was in fact RNA; later experiments used substrates that had a longer stretch of RNA nucleotides (see below). Because the RNA substrate during the selection process was 5'-biotinylated, successful RNA cleavage also separated the biotin tag from the 50 nt (N₅₀) DNA random region. This allowed the isolation of catalytically active DNA sequences by streptavidin chromatography, because the functional DNA sequences lost their biotin tag and were not retained on the column. As in essentially all selection efforts, the ‘winning’ deoxyribozyme sequences that survived a particular selection round were used to initiate another round of selection, and the entire process was iterated multiple times.

View larger version (18K): [in this window] [in a new window]   Figure 2 In vitro selection strategies for identifying RNA-cleaving deoxyribozymes. (A) The general four-step selection strategy, which involves iterated rounds of PCR to incorporate biotin; streptavidin chromatography to isolate the single-stranded nucleic acid; M2+-catalyzed RNA cleavage; and PCR to regenerate the pool, which has been enriched in deoxyribozymes capable of cleaving RNA. (B) Simplified depictions of the three strategy variations used in all selection experiments for RNA-cleaving DNA enzymes reported to date. In strategy 1, a single ribonucleotide linkage (rA) is the cleavage target, and interactions between the substrate strand and the deoxyribozyme are not pre-programmed. This strategy was used for the first in vitro selection effort that identified catalytic DNA, which resulted in a Pb2+-dependent RNA-cleaving deoxyribozyme (26), and it has been employed in other studies as well (28,33). In strategy 2, the single ribonucleotide cleavage site was placed between two Watson–Crick binding arms, as first reported by Breaker and Joyce (27) and used in several subsequent experiments (30,32,33,36,40). In strategy 3, a 12 nt stretch of RNA rather than a single ribonucleotide linkage was the cleavage target, giving rise to the 10–23 and 8–17 deoxyribozymes (29). The biotinylated RNA–DNA chimera was generated during the first step of each selection round by primer extension using reverse transcriptase instead of PCR (not depicted explicitly).

 
At the end of the selection procedure, when sufficiently high RNA cleavage activity was present in the pool as a whole, individual deoxyribozyme sequences were identified by standard cloning procedures. The new Pb²⁺-dependent deoxyribozyme was found to interact with the RNA substrate using Watson–Crick binding arms on either side of the initially random enzyme region (sometimes called the catalytic core), as shown in Figure 3A. This modular arrangement spatially separates binding and catalytic functions and has subsequently been found for many of the deoxyribozymes that cleave RNA, as described below. As originally obtained, the Pb²⁺-dependent deoxyribozyme cleaves near its own 5'-terminus (cleavage in cis). Because of the simple Watson–Crick nature of the deoxyribozyme-substrate interactions, engineering the Pb²⁺-dependent DNA enzyme to work intermolecularly (in trans) was achieved in straightforward fashion by removing the covalent loop that connects the RNA substrate with the DNA.

View larger version (27K): [in this window] [in a new window]   Figure 3 Gallery of RNA-cleaving deoxyribozymes identified by in vitro selection. Most of these deoxyribozymes function in the intermolecular format for in trans cleavage of an RNA linkage. Thick lines and lowercase letters denote RNA; thin lines and uppercase letters denote DNA, and the green arrow marks the cleavage site. The DNA enzyme regions are green; DNA nucleotides involved in Watson–Crick base pairing are brown; nucleotides of the substrate to the 5'-side of the cleavage site are red; and nucleotides to the 3'-side are blue. For clarity, not all nucleotides are shown explicitly, but this does not necessarily imply a lack of sequence requirements. In panel D, the 8–17 deoxyribozyme is shown with the RNA cleavage site requirement ag. However, the closely related 17E deoxyribozyme (32) can cleave ng (although ag and gg are preferred). Furthermore, a comprehensive study showed that 8–17 variants can be identified that collectively cleave almost any RNA dinucleotide linkage (36). In panel H, the letters F and Q denote a fluorophore and quencher that are separated upon cleavage by the signaling deoxyribozyme.

 
When the substrate for the Pb²⁺-dependent deoxyribozyme was replaced with an all-RNA analogue (i.e. not just a single RNA linkage at the cleavage site), catalytic activity was nearly abolished. This suggested that identification of deoxyribozymes for cleavage of all-RNA substrates—which would be of greater practical value—may require use of all-RNA substrates during the selection procedure itself. The Pb²⁺-dependent deoxyribozyme cleaved the lone RNA linkage in trans with k_cat = 1 min^–1 and K_m = 2 µM at 1 mM Pb²⁺ (pH 7.0) and 23°C (with 0.5 M each NaCl and KCl present as well). From these values, k_cat/K_m =5 x 10⁵ M^–1 min^–1, and multiple-turnover was clearly evident; e.g. 46 turnovers were observed in 90 min. The uncatalyzed rate of RNA cleavage under the same conditions (i.e., spontaneous RNA cleavage in the absence of the deoxyribozyme) was k_uncat = 10^–5 min^–1, leading to a calculated rate enhancement k_cat/k_uncat of 10⁵. This value is near that of the hammerhead ribozyme (41). Therefore, despite earlier speculation to the contrary (42), even this initial experimental study suggested that deoxyribozymes have no inherent functional limitations relative to their ribozyme cousins, despite the absence of 2'-hydroxyl groups in DNA.

Breaker and Joyce (27) immediately followed up their first study by identifying a Mg²⁺-dependent RNA-cleaving deoxyribozyme. In this second effort, an N₄₀ DNA region was explicitly positioned between two binding arm regions that interacted with their nucleic acid substrate by Watson–Crick base pairs (Figure 2, strategy 2). As in the first effort, a cleavage substrate with only a single ribonucleotide linkage was used. After six rounds of selection, an initial DNA enzyme clone had k_obs = 0.002 min^–1 under single-turnover conditions at 1 mM Mg²⁺ (pH 7.0) and 23°C. Re-selection was performed by partially randomizing the enzyme region to the extent of 15% at each nucleotide and performing seven additional selection rounds (thereby technically making this an ‘evolution’ experiment, because evolution is selection coupled with introduction of variation after the start of the experiment). The overall effort led to the E2 deoxyribozyme (Figure 3B), which has k_obs = 0.01 min^–1 at 1 mM Mg²⁺ and k_obs =0.08 min^–1 under saturating Mg²⁺ of >100 mM. As observed for the Pb²⁺-dependent deoxyribozyme, the rate enhancement k_obs/k_uncat of E2 was about 10⁵, and an all-RNA substrate was not cleaved.

A third selection effort for RNA-cleaving deoxyribozymes was undertaken by Faulhammer and Famulok (28). These investigators originally sought a histidine-dependent deoxyribozyme and thus included only a small amount of Mg²⁺ (0.5 mM) in their experiments, which were performed using a selection strategy similar to that used in the initial Pb²⁺ effort (strategy 1 of Figure 2). Here, an N₇₄ region and 10 selection rounds were used, again with a single ribonucleotide linkage as the cleavage site. Surprisingly, the resulting Mg5 deoxyribozyme was histidine-independent and preferred Ca²⁺ over Mg²⁺ as the metal ion cofactor, although Ca²⁺ was never present during the selection protocol. Indeed, Ca²⁺ was favored by an order of magnitude in rate over Mg²⁺, with k_cat for Ca²⁺ of 0.1 min^–1 and K_m = 6 µM at 10 mM Ca²⁺ (pH 7.0) and 37°C (k_cat/K_m = 1.6 x 10⁴ M^–1 min^–1). The rate enhancement k_cat/k_uncat for Ca²⁺ was 10⁴ (43).

	IN VITRO SELECTION OF DEOXYRIBOZYMES THAT CLEAVE RNA, PART 2: THE SECOND GENERATION OF EXPERIMENTS

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
Because all three of the initially identified deoxyribozymes could not cleave an all-RNA substrate, which was never available to the DNA during the selection procedure itself, it seemed opportune to perform a selection experiment in which the substrate had a long stretch of ribonucleotides as the cleavage target. In addition, although the rate enhancements over the uncatalyzed background cleavage rate were high in the initial investigations, catalytic parameters such as k_cat/K_m were suboptimal. Santoro and Joyce (29) addressed both of these issues in a landmark study that provided what has become the two most commonly used RNA-cleaving deoxyribozymes. Their experiment used a modified selection approach in which an all-RNA substrate strand was presented to an N₅₀ DNA pool, which could cleave anywhere along the 12 nt length of the RNA sequence (Figure 2, strategy 3).

After 8–10 rounds of selection, cleavage was observed at two favored sites within the 12 nt RNA region. The 8–17 and 10–23 deoxyribozymes (each of which were named for the round and clone number by which they were identified) were chosen for further study because they interacted with the RNA substrate using simple Watson–Crick binding arms, which would facilitate practical applications. Re-selections starting with the initially cloned sequences were used to provide information on the optimal catalytic cores (Figure 3C and D). For 10–23, k_cat = 0.15 min^–1 and K_m = 0.5 nM under simulated physiological conditions of 2 mM Mg²⁺, 150 mM NaCl (pH 7.5), and 37°C (k_cat/K_m = 3 x 10⁸ M^–1 min^–1). Because the apparent K_m for Mg²⁺ under these conditions was much higher (180 mM), k_cat at 2 mM Mg²⁺ was clearly not maximal. Under more typical in vitro conditions of 50 mM Mg²⁺ (pH 8.0) and 37°C, k_cat = 3 min^–1 and K_m = 0.8 nM (k_cat/K_m = 4 x 10⁹ M^–1 min^–1). This value of k_cat/K_m is 1–2 orders of magnitude higher than for the naturally occurring hammerhead or hairpin RNA-cleaving ribozymes, further demonstrating that DNA has no inherent catalytic inferiority relative to RNA. As noted by the authors, 10–23's value of k_cat is much less favorable (by 10⁴-fold) than k_cat for a protein ribonuclease such as RNase A, but 10–23's value of K_m is much more favorable (by 10⁵-fold). Thus, by the k_cat/K_m criterion, deoxyribozymes are at least as good as—if not better than—protein enzymes at cleaving RNA. However, it is clear that a very favorable K_m for 10–23 and related deoxyribozymes can be obtained simply by increasing the binding arm lengths. This is because more Watson–Crick base pairs lead to tighter binding, and of course such a strategy is not available to a protein enzyme. It is important to note that the favorable deoxyribozyme K_m is eventually achieved at the expense of multiple turnover as the binding arm strengths continue to be increased, because product release soon becomes rate-limiting.

Three subsequent studies revealed remarkable convergence upon the catalytic core motif of the 8–17 deoxyribozyme across several selection experiments. In one investigation, Peracchi performed a comprehensive mutagenesis analysis of the 8–17 deoxyribozyme and found that most mutants—as well as the parent DNA enzyme itself—functioned with 10- to 20-fold higher k_obs in the presence of Ca²⁺ instead of Mg²⁺ (31). This was reminiscent of the Ca²⁺-dependent Mg5 deoxyribozyme described above (28), and indeed the Mg5 deoxyribozyme was shown in this same study to incorporate the 8–17 motif within its conserved core. When several noncanonical interactions within the substrate binding arms of the originally identified Mg5 deoxyribozyme were converted to Watson–Crick base pairs, its catalytic activity was improved. These changes also conferred upon Mg5 the ability to cleave an all-RNA substrate, unlike the original Mg5 construct but similar to 8–17 itself. In essence, Mg5 is the 8–17 deoxyribozyme in masked form, although this relationship did not become clear until 8–17 itself was formally identified (29) and direct comparisons were made.

In a second investigation, Lu and coworkers (32) used selection strategy 2 of Figure 2 with the focused goal of finding DNA enzymes that operate with transition metal ion cofactors like Zn²⁺ rather than alkaline earth metals like Mg²⁺ or Ca²⁺. They successfully identified the Zn²⁺-dependent 17E deoxyribozyme, which—like the Mg5 deoxyribozyme—was found to have the 8–17 catalytic core. An explanation for the varying divalent metal ion dependencies of 8–17 and 17E was unclear on the basis of their data. Although 8–17 itself was reported to cleave only AG RNA linkages (29), 17E cleaves AG and GG equally well and about an order of magnitude faster than it cleaves either UG or CG.

Finally, in a comprehensive effort, Li and coworkers (36) identified a family of 8–17-like deoxyribozymes that collectively cleave almost any RNA dinucleotide junction. Their selection strategy was initially designed to identify entirely new RNA-cleaving deoxyribozymes using strategy 2 of Figure 2. However, closely related variants of the 8–17 catalytic motif rapidly came to dominate all of the pools. This was strong evidence that the 8–17 motif is the simplest solution for the RNA cleavage problem and therefore highly favored in DNA sequence space, just as the small hammerhead ribozyme motif is favored in RNA sequence space (44).

Considering the interest in the roles of metal ions in nucleic acid catalysis, Geyer and Sen (30) sought RNA-cleaving deoxyribozymes that functioned independently of divalent metal ions, M²⁺. At the time of their study (1997), the ability of some natural ribozymes to function without M²⁺ was not yet appreciated (45–47), so their effort was particularly thought-provoking. Using strategy 2 of Figure 2, the self-cleaving Na8 deoxyribozyme (Figure 3E) was identified after 12 selections rounds, cloning and six additional selection rounds. The k_obs for the Na8 deoxyribozyme was relatively modest [0.007 min^–1 at 0.5 M NaCl (pH 7.0) and 25 °C], but considering the estimated k_uncat of only 3 x 10^–10 min^–1 in the absence of M²⁺, the rate enhancement k_obs/k_uncat of 2 x 10⁷ was remarkable. The M²⁺-independence of the Na8 deoxyribozyme was convincingly demonstrated via a wide range of control measures and analytical assays. Adding common divalent metal ions such as Mg²⁺, Ca²⁺ or Zn²⁺ had no effect upon activity. Furthermore, these M²⁺ were ineffective in the absence of Na⁺, whereas monovalent ions other than Na⁺ were also effective cofactors. Several of the RNA-cleaving deoxyribozymes from a separate effort by Faulhammer and Famulok (28) as mentioned above are clearly related to Na8 by sequence (30) and were shown to be metal-independent DNA enzymes as well (43).

Another study from the Sen laboratory led to a DNA enzyme with no apparent relationship to the 8–17 deoxyribozyme (33). Using an N₄₀ random region along with strategy 1 of Figure 2 for 12 rounds of selection with a single ribonucleotide in the substrate; cloning; and then seven rounds of re-selection with a substrate incorporating several ribonucleotides, the ‘bipartite DNAzyme’ was identified (Figure 3F). This deoxyribozyme also interacts with its RNA substrate using Watson–Crick binding arms, but it prefers several unpaired nucleotides near the cleavage site. Under multiple-turnover conditions with one particular substrate, k_cat = 1 min^–1 and K_m = 200 nM [30 mM Mg²⁺ (pH 7.4), 37°C]. The value of k_cat/K_m = 5 x 10⁶ M^–1 min^–1 is only an order of magnitude lower than such values for natural ribozymes such as the hammerhead and hairpin ribozymes. An independent effort by Benner's group led to the ‘614 deoxyribozyme’ that is Mg²⁺-independent and also unrelated to 8–17 (48).

Protein enzymes commonly use organic cofactors for catalysis, so Roth and Breaker (40) sought to determine if RNA-cleaving deoxyribozymes could depend not on divalent metal ions but on a cofactor. Using strategy 2 of Figure 2 with an N₄₀ region, and including EDTA to ensure the absence of free M²⁺, they identified several histidine-dependent deoxyribozymes such as HD2 (Figure 3G). This process took 11 rounds of selection followed by five rounds of re-selection, and the resulting deoxyribozymes indeed require L-histidine as a cofactor with K_d,app of 25 mM or greater. The pH dependence of the reaction suggested a general base role for the imidazole moiety of histidine during catalysis. The HD2 deoxyribozyme requires K⁺ as well as imidazole, suggesting the involvement of K⁺-dependent DNA structures such as G quartets.

	TWO PRACTICAL CONSIDERATIONS FOR THE SELECTION EXPERIMENTS

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
In all of the above studies, streptavidin (or a related protein) and a biotinylated substrate were used as the physical basis of the selection effort. In principle, gel-based methods could instead be used to separate products on the basis of size changes after RNA cleavage, analogous to what has been done recently to identify deoxyribozymes that ligate RNA (49). Nevertheless, the biotin-based methods appear to be quite effective for identifying RNA-cleaving deoxyribozymes, so other methods have not been necessary in practice.

It may not be immediately obvious why all of these selection procedures need to be iterated for multiple rounds to identify catalytically active DNA sequences. If only particular DNA sequences are catalytically competent to cleave RNA, then why are they not identified in just a single round of selection? The resolution of this issue lies in recognizing that without exception, every DNA sequence has a nonzero probability of having the attached RNA substrate become cleaved during the allotted incubation time. For most DNA sequences drawn from a random pool, this probability is quite low; the DNA sequence is essentially ‘inactive’, and RNA cleavage is not catalyzed by the attached DNA. However, there are a very large number of such catalytically incompetent DNA sequences in the initial pool. For a typical 200 pmol initial pool (10¹⁴ molecules), even if a large number (e.g., 10⁶) of the DNA sequences truly have substantial RNA cleavage activity, the vast majority of the pool (10¹⁴ – 10⁶ 10¹⁴ molecules) consists of ‘inactive’ DNA sequences. Simply by chance, some of these nominally inactive DNA sequences will have their RNA substrate cleaved during any particular incubation period, and these inactive DNA sequences will thus survive the selection round. The fraction of the pool that contains truly catalytically competent DNA sequences increases during each round of the selection procedure; i.e., the pool becomes enriched in catalytically active sequences. However, multiple rounds are always needed in practice for this enrichment to reach the point where the truly active sequences constitute the dominant population. Experience suggests that 4–10 rounds are typically needed for unambiguous RNA cleavage activity to emerge from a random DNA pool of length N₄₀–N₅₀. Of course, the exact number of rounds to observe this emergence depends strongly on the details of the selection design.

	CHARACTERIZATION OF DEOXYRIBOZYMES THAT CLEAVE RNA

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
The rate constants and catalytic efficiences included within the above descriptions show that highly active RNA-cleaving deoxyribozymes can be obtained by in vitro selection. In terms of mechanism, diffusion-controlled catalytic efficiency k_cat/K_m in the range of 10⁹ M^–1 min^–1 with considerable turnover (29,50) indicates that product release is not necessarily rate-limiting. Although RNA-cleaving deoxyribozymes are often well-behaved in terms of their kinetics, in at least one case the 10–23 deoxyribozyme was observed to have biphasic kinetics under single-turnover conditions (51), which suggests the potential for mechanistic complexity. In general, the mechanisms of RNA-cleaving deoxyribozymes are poorly understood, and this is an area deserving of experimental attention.

For many years, it was thought that all ribozymes are obligatory metalloenzymes; i.e., that they require metals with valence of two or more (52,53). However, a number of studies have shown that some natural ribozymes can function without divalent metal ions, although in such cases unusually high concentrations of monovalent metal ions (e.g. 4 M Li⁺) are typically necessary (45–47). Similarly, some RNA-cleaving deoxyribozymes such as Na8 do not require divalent metal ion cofactors (30,43). Because the mechanisms of RNA-cleaving deoxyribozymes are poorly understood, the implications of divalent metal ion dependence (or independence) are unclear. Curiously, binding of Ca²⁺ to the Mg5 deoxyribozyme involves at least two cooperative binding events in the intramolecular form of cleavage, whereas Mg²⁺ binding does not involve cooperativity (43). For a shortened version of the 10–23 deoxyribozyme termed ML6, a specific nucleotide deletion switched the metal dependence of activity from favoring Mg²⁺ to favoring Ca²⁺ (54). Overall, the roles of divalent metal ions in DNA-catalyzed RNA cleavage appear to be complicated.

The pH value is another experimental variable that can be manipulated to provide information on deoxyribozyme mechanisms. When they have been examined, most RNA-cleaving deoxyribozymes are found to have a log-linear dependence of rate on pH with slope near unity (32,50,55). This is consistent with the requirement for a single deprotonation event during the reaction, similar to many ribozymes in this regard (56–59). In contrast, the relative pH-independence of the Na8 deoxyribozyme and the ‘bipartite DNAzyme’ resembles that of the HDV ribozyme and suggests acid-base catalysis rather than metal-ion-assisted 2'-hydroxyl deprotonation (30,33). However, this type of mechanism has not yet been demonstrated experimentally for deoxyribozymes.

A common feature for all of the known RNA-cleaving deoxyribozymes is the unpaired nature of the ribonucleotide at the cleavage site. This unpaired nucleotide has plausibly been speculated to provide the structural flexibility necessary to allow an in-line attack conformation of the attacking 2'-hydroxyl nucleophile (39,43), although more direct experimental support for this hypothesis must be obtained. Several of the RNA-cleaving deoxyribozymes (e.g. Na8 and ‘bipartite’) prefer several unpaired nucleotides in the substrate near the cleavage site (Figure 3). Because the 10–23 and 8–17 deoxyribozymes need only one such unpaired nucleotide, this suggests different structural constraints upon the respective cleavage mechanisms. It may not be a coincidence that the Na8 deoxyribozyme and the ‘bipartite DNAzyme’ differ from 10–23 and 8–17 in both the nucleotide pairing near the cleavage site and the pH dependence of their reactivity.

For proteins and nucleic acids alike, mutagenesis is a common approach to explore structure-function studies. Mutational analysis of the enzyme region has been performed for several RNA-cleaving deoxyribozymes, including 10–23 (60) and 8–17 (31,61). Effects of mutations to the 10–23 binding arms near the cleavage site have also been examined, and rather subtle modifications were found to have a strong influence upon activity (62). Additional biophysical analysis of both folding and function has been performed for the 10–23 deoxyribozyme (63–65), the 8–17 deoxyribozyme (66–68) and the original Pb²⁺-dependent deoxyribozyme (69).

From the structural biology viewpoint (i.e. X-ray crystallography and NMR spectroscopy), almost nothing is known about deoxyribozymes that cleave RNA. Only one attempt to crystallize a deoxyribozyme has been reported, using the 10–23 deoxyribozyme (70). However, the structure was not of the catalytically active RNA:DNA complex (71), so mechanistic information could not be inferred (the structure was instead an interesting 2:2 RNA:DNA complex that resembles a Holliday junction). Precise and mechanistically relevant high-resolution structural information on any RNA-cleaving deoxyribozyme will hopefully be obtained in the near future. These efforts should be particularly informative with regard to understanding the metal-ion dependence of RNA-cleaving deoxyribozymes. Likely targets for study are the 8–17 variants that prefer Mg²⁺, Ca²⁺ or Zn²⁺ as well as the 8–17-related Na8 deoxyribozyme that is M²⁺-independent, along with other deoxyribozymes that have curious metal dependencies such as the ‘bipartite DNAzyme’ (33).

	APPLICATION OF DEOXYRIBOZYMES THAT CLEAVE RNA AS IN VITRO ‘RESTRICTION ENZYMES’ FOR RNA

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
A significant reason to study nucleic acid enzymes is their conceptual relevance for understanding catalysis by naturally occurring nucleic acids, and the efforts described above indicate the progress in this regard. Artificial ribozymes and deoxyribozymes may also be used for practical applications. Deoxyribozymes are being applied with ever-increasing frequency as straightforward laboratory reagents for cleavage of specific RNA sequences—essentially, as ‘restriction enzymes’ for RNA (72). The 10–23 and 8–17 deoxyribozymes are currently the workhorses for this purpose. The potential use of DNA for practical RNA cleavage was recognized in the initial report that described 10–23 and 8–17 (29), and other instances have since been reported. For example, RNA-cleaving deoxyribozymes have been used to assist with large-scale RNA preparation for structural biology experiments (73) and for small-scale RNA cleavage reactions (74–76). Other applications along these lines are noted in a later section.

The original 10–23 and 8–17 deoxyribozymes have substrate sequence requirements of RY and AG, respectively, where R denotes a purine (A or G) and Y is a pyrimidine (U or C). Despite these limitations, 10–23 and 8–17 are quite useful in practice. The family of 8–17-like deoxyribozymes obtained by Li and coworkers (36) expands the range of RNA sequences that may be cleaved, thus providing a nearly universal means of cleaving RNA using catalytic DNA. With the 8–17 variants of Li and coworkers, most dinucleotide sequences NN may be cleaved in vitro with reasonable rate by choosing the appropriate deoxyribozyme; only the combinations YC and NU are consistently poor substrates. In our laboratory, we routinely use their 8–17 variants to cleave RNA sequences for preparative purposes and also during in vitro selection procedures that require RNA cleavage (77,78) (S. K. Silverman and coworkers, unpublished data). In general, for in vitro applications in which an RNA substrate needs to be cleaved site-specifically, a deoxyribozyme such as 10–23 or 8–17 (or one of their variants) should be considered for this purpose.

For a deoxyribozyme to cleave its RNA target, binding between the DNA and RNA must occur. A proposed rule of thumb for designing the binding arms is that each arm should have a binding free energy (G°) of at least 10–12 kcal/mol (72), as calculated on the basis of tabulated RNA:DNA interaction energies (79). This is a good guideline when the deoxyribozyme is used in excess of the cleavage substrate; i.e., under single-turnover conditions. In contrast, multiple-turnover conditions require that the deoxyribozyme dissociate from the cleavage products, which suggests the use of shorter binding arms. For in vitro applications, an excess of deoxyribozyme can generally be used, and greater binding affinity ensures maximal RNA cleavage activity. Another benefit of longer Watson–Crick RNA:DNA binding arms is that including additional DNA nucleotides can help to disrupt secondary structure near the cleavage site in the RNA target, when such secondary structure would otherwise inhibit binding of the DNA. Similarly, modifying the deoxyribozyme's binding arms by incorporating 2'-methoxy or locked nucleic acid (LNA) nucleotides can markedly improve cleavage activity by increasing the binding affinity for the RNA target (80–82).

	APPLICATION OF DEOXYRIBOZYMES THAT CLEAVE RNA FOR IN VIVO TARGETING OF mRNA

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
A logical extension of DNA's ability to cleave RNA in vitro is the application of RNA-cleaving deoxyribozymes for cleaving mRNAs in vivo. Several reviews have been published concerning in vivo mRNA cleavage by deoxyribozymes (83–85), some of which include extensive tables and literature references (86–89). A growing number of individual reports have described the in vivo application of RNA-cleaving deoxyribozymes to degrade mRNA in cell culture and sometimes even in animal models; representative examples are cited here (51,90–99). In general, RNA-cleaving deoxyribozymes should have an important place alongside other in vivo therapies that are based on nucleic acids, such as antisense oligonucleotides, RNA-cleaving ribozymes and siRNA (86,100–103).

Several issues that are not of concern for in vitro applications become essential to consider for in vivo studies. The deoxyribozyme must be delivered intracellularly to interact with its mRNA target. Single-stranded DNA expression vectors (104–109), electroporation (110), and modified delivery agents (111) have been used for this purpose. Once inside a cell, the DNA must remain stable on a relevant timescale. The use of modified LNA nucleotides, which enhances substrate binding affinity as noted above, additionally helps to increase specificity in targeting a desired mRNA among all of the other RNAs within a cell (112). To suppress nuclease degradation, covalent conjugation (113) or terminal modification of deoxyribozymes have been used (114,115). Sometimes more than one stabilization strategy has been applied simultaneously (116).

Due to the complexities of living cells, extrapolating efficacy from in vitro assays is sometimes misleading, and it can be frustrating to find experimentally that a deoxyribozyme known to work in vitro fails in vivo. One reason for such failure may be the fact that deoxyribozymes such as 10–23 and 8–17 were identified by in vitro selection using different RNA substrates than are actually targeted in a particular in vivo experiment. In such cases, it would be sensible to identify deoxyribozymes that specifically cleave precisely the desired target sequence; such an effort is justified if cleavage of the particular target is a sufficiently valuable objective. Towards this goal, as was done independently with ribozymes (117), selections were performed starting with a known 10–23 deoxyribozyme sequence and selecting for particularly accessible cleavage sites in a certain mRNA target, which were then successfully exploited in vivo using the newly identified deoxyribozymes (118).

Cleavage of an mRNA molecule can be viewed not only as a goal in itself, but also as the first step in a multi-step cleavage/ligation route for repairing aberrant mRNAs. Indeed, ribozyme-mediated RNA repair processes have been described (88,119–123). No deoxyribozymes have been reported for this purpose, but the possibility is intriguing, particularly because of the advantages of deoxyribozymes over ribozymes for mRNA cleavage applications in terms of cost and in vivo stability.

	APPLICATION OF DEOXYRIBOZYMES THAT CLEAVE RNA AS SENSORS

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
A sensor can be created by the combination of a molecular recognition event for a particular analyte with a signaling event. Nucleic acid enzymes are particularly amenable to sensor applications because their catalytic activities can be modulated by specific analytes and because these activities can be transduced into optically detected changes in several ways. The Lu research group interfaced a Pb²⁺-dependent RNA-cleaving deoxyribozyme (32) with optical assays to create sensitive Pb²⁺ detectors. In these experiments, Pb²⁺ is a required cofactor for DNA-catalyzed RNA cleavage, so the sensor is directly activated by the metal ion analyte. As shown in Figure 4A, cleavage of an RNA substrate that is labeled with both a fluorophore and a quencher (e.g., TAMRA and Dabcyl) results in a fluorescence increase due to physical separation of the quencher from the fluorophore (124). Several improvements to this system were made (125,126), including the use of surface immobilization to improve the detection limit to 10 nM Pb²⁺ (127). Alternatively, gold nanoparticle technology was exploited to design colorimetric Pb²⁺ sensors, using the principle that DNA-catalyzed RNA cleavage disrupts gold nanoparticle aggegations, which changes the color from blue to red (Figure 4B) (128). The same group also designed an allosteric deoxyribozyme sensor for adenosine by integrating an adenosine aptamer unit into the complex between deoxyribozyme and RNA substrate (Figure 4C) (129). The latter approach is related to a sensing assay reported by Sen and coworkers (130–132), in which binding of the oligonucleotide regulator was not dependent on binding of a separate analyte; thus their system directly sensed the oligonucleotide regulator itself. In general, such methods have great promise for development of sensors based on RNA-cleaving deoxyribozymes (22,133).

View larger version (17K): [in this window] [in a new window]   Figure 4 RNA-cleaving deoxyribozymes as sensors. (A) Transducing DNA-catalyzed RNA cleavage into a fluorescence signal by separation of a fluorophore and a quencher. These are denoted F and Q, respectively (e.g., TAMRA and Dabcyl, although other combinations may be used). The fluorophore and quencher may be placed in various places on the RNA substrate and deoxyribozyme, as long as RNA cleavage results in physical separation of F and Q (125). (B) Using gold nanoparticles to induce a colorimetric signal upon RNA cleavage, which separates the nucleic acid strands that hold the nanoparticles together in an aggregate. The RNA substrates are colored brown to avoid confusion with the aggregated (blue) and separated (red) gold nanoparticles. The gold nanparticles are shown in a ‘head-to-tail’ orientation (128,129,134), but subsequent efforts showed that a ‘tail-to-tail’ orientation is optimal (126,135). (C) An allosteric adenosine sensor that was engineered by combining an aptamer with a deoxyribozyme (129). The deoxyribozyme binds well to the RNA substrate only when adenosine (orange) is bound with the aptamer (pink), whereupon RNA cleavage is transduced to a color change via separation of the gold nanoparticles.

 
In separate efforts, Li and coworkers used in vitro selection to identify fluorescently signaling RNA-cleaving deoxyribozymes (34), a collection of which has very broad specificities for pH and metal ions (35). A key element of these studies was that the fluorophore and quencher combination were present throughout each selection effort, rather than being grafted onto a functional deoxyribozyme at the end of the selection process. Therefore, the desired fluorescence signaling activity was directly identified. The Li group has recently characterized one of their signaling deoxyribozymes, pH6DZ1, finding that it has a rather complex secondary structure when compared with 10–23 and 8–17 (Figure 3H) (136). Although not technically RNA-cleaving deoxyribozymes, an entire collection of ‘structure-switching signaling aptamers’ has also been created by the same research group (137). In these designs, an interaction between a nucleic acid and an analyte controls a fluorescence signal without any catalytic events. It is likely that the principles from these experiments can be adapted for regulation of deoxyribozyme catalysis. Indeed, the first report of a signaling deoxyribozyme also described creation of an ATP-dependent allosteric sensor (34), and another effort along these lines was recently reported (138).

Other researchers have used RNA-cleaving deoxyribozymes as sensors in other ways. For example, Stojanovic and coworkers (139) have created fluorescent oligonucleotide sensors and also detected protein–ligand interactions by tethering biotin to a deoxyribozyme's RNA substrate and modulating RNA cleavage activity with streptavidin. In general, combining the principles of deoxyribozyme catalysis with various types of sensor assays appears to be a fruitful approach for practical sensor development.

	OTHER APPLICATIONS OF DEOXYRIBOZYMES THAT CLEAVE RNA

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
RNA-cleaving deoxyribozymes have been applied for purposes beyond those mentioned above. For example, such deoxyribozymes have been used for detecting in vitro-generated RNA modifications (140); for mapping sites of in vitro RNA crosslinking (141); for mapping RNA branch points (72,142,143); for probing higher-order RNA structure (144); for quantifying nucleic acid production during PCR amplification (145); for analyzing nucleic acid sequence mutations (146); for detecting specific microbial rRNAs (147); for constructing logical computation circuits (148–151); and for manipulating a DNA-based nanodevice (152). A deoxyribozyme has been identified that cleaves unnatural RNA linkages, which may be useful for certain biotechnology applications (153). It is likely that additional interesting applications of RNA-cleaving deoxyribozymes will be developed in the future.

	RNA-CLEAVING DEOXYRIBOZYMES WITH NONSTANDARD NUCLEOTIDES

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
RNA-cleaving deoxyribozymes with protein-like functional groups have been selected from random-sequence DNA pools that were prepared incorporating one or more unnatural nucleotides (154–157). These unnatural nucleotides incorporate functionality such as imidazole and primary amino groups, which are not found among the natural DNA nucleobases. In some cases, use of such unnatural nucleotides requires a technical advance in the selection methodology; e.g., more tolerant DNA polymerases need to be identified (158). A complete discussion of the catalytic possibilities that are enabled by inclusion of unnatural nucleotides is beyond the scope of this review. Nevertheless, it is clear that in principle, including unnatural functional groups allows chemical possibilities beyond those provided by standard DNA alone. Of course, for practical applications it must be determined empirically whether or not these new chemical possibilities justify the synthetic effort necessary to use nonstandard DNA nucleotides in identifying new deoxyribozymes.

Nonstandard functional groups within nucleic acid enzymes are not limited to those such as imidazole with special acid-base properties. For example, at least two research groups have described photochemically controlled deoxyribozymes (159,160). This shows that unnatural nucleotides can be incorporated into DNA enzymes not for their direct catalytic contributions but because they can modulate deoxyribozyme function. Unnatural nucleotides can also be used to stabilize the deoxyribozymes against nuclease degradation (161), which is important for in vivo applications.

	DEOXYRIBOZYMES THAT LIGATE RNA

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
RNA ligation by a deoxyribozyme is conceptually the ‘opposite’ of RNA cleavage, because two RNA strands are joined instead of cleaved. If the appropriate functional groups are involved, then RNA ligation by a deoxyribozyme can be the precise mechanistic reverse of cleavage as well. Our own research group has focused strongly on identifying deoxyribozymes that ligate RNA. In contrast to the uniform reaction pathway of RNA cleavage (Figure 1), DNA-catalyzed RNA ligation can occur in many ways, depending on the identities of the substrates and the pathways by which they can react. Not surprisingly, a wider variety of chemical reactions has been observed for DNA-catalyzed RNA ligation when compared with RNA cleavage [see (78,162,163) and references therein]. These RNA ligation experiments offer insight into the workings of nature's nucleic acid catalysts such as the ribosome (5) and spliceosome (2,3), which also modulate bond-forming reactions. Furthermore, some RNA-ligating deoxyribozymes provide routes to important biomolecular targets such as lariat RNAs that would be challenging or impossible to prepare by other means (163). Therefore, RNA-ligating deoxyribozymes offer practical utility as well as conceptual insights. Applications of deoxyribozymes that ligate RNA will certainly increase in parallel with the applications of deoxyribozymes that cleave RNA.

	PERSPECTIVE

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 
In only a little over a decade since their initial identification, artificial RNA-cleaving deoxyribozymes have grown from a laboratory curiosity into widely appreciated research tools both in vitro and in vivo. Fundamental investigations of these deoxyribozymes should continue to offer substantial insight into how catalysis can be achieved with nucleic acid enzymes. For example, the identification of histidine-dependent deoxyribozymes (40) prompts a more general question: what are the limits and implications of DNA and RNA catalysis that is mediated by organic cofactors? Equally important are the opportunities enabled by combining DNA-catalyzed RNA cleavage with practical applications. Such applications currently range from in vitro preparative reactions to in vivo mRNA degradation to realistic sensor systems. In all of these areas, improvements can be expected. For example, a future direction likely lies in using array technologies to exploit RNA-cleaving deoxyribozyme sensors to the greatest possible extent, much as ribozyme arrays are currently being explored (164). One may anticipate that microfluidic and nanofluidic technologies (165) will also be integrated into devices for applications that depend upon RNA-cleaving deoxyribozymes.

	ACKNOWLEDGEMENTS

 
Research on deoxyribozymes in the Silverman laboratory has been supported by the Burroughs Wellcome Fund (New Investigator Award in the Basic Pharmacological Sciences), the March of Dimes Birth Defects Foundation, the National Institutes of Health, the American Chemical Society Petroleum Research Fund, and the UIUC Department of Chemistry. S.K.S. is the recipient of a fellowship from The David and Lucile Packard Foundation. The Open Access publication charges for this article were waived by Oxford University Press.

Conflict of interest statement. None declared.

	REFERENCES

TOP ABSTRACT INTRODUCTION IN VITRO SELECTION OF... IN VITRO SELECTION OF... TWO PRACTICAL CONSIDERATIONS FOR... CHARACTERIZATION OF... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... APPLICATION OF DEOXYRIBOZYMES... OTHER APPLICATIONS OF... RNA-CLEAVING DEOXYRIBOZYMES WITH... DEOXYRIBOZYMES THAT LIGATE RNA PERSPECTIVE REFERENCES

 

1. Doudna, J.A. and Cech, T.R. (2002) The chemical repertoire of natural ribozymes Nature, 418, 222–228[CrossRef][Medline] .

2. Collins, C.A. and Guthrie, C. (2000) The question remains: is the spliceosome a ribozyme? Nat. Struct. Biol., 7, 850–854[CrossRef][Web of Science][Medline] .

3. Villa, T., Pleiss, J.A., Guthrie, C. (2002) Spliceosomal snRNAs: Mg²⁺-dependent chemistry at the catalytic core? Cell, 109, 149–152[CrossRef][Web of Science][Medline] .

4. Ban, N., Nissen, P., Hansen, J., Moore, P.B., Steitz, T.A. (2000) The complete atomic structure of the large ribosomal subunit at 2.4 Å resolution Science, 289, 905–920[Abstract/Free Full Text] .

5. Cech, T.R. (2000) The ribosome is a ribozyme Science, 289, 878–879[Free Full Text] .

6. Gilbert, W. (1986) The RNA world Nature, 319, 618 .

7. In Gesteland, R.F., Cech, T.R., Atkins, J.F. (Eds.). The RNA World, 2nd edn, (1999) Cold Spring Harbor, NY Cold Spring Harbor Laboratory Press .

8. Tuerk, C. and Gold, L. (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase Science, 249, 505–510[Abstract/Free Full Text] .

9. Ellington, A.D. and Szostak, J.W. (1990) In vitro selection of RNA molecules that bind specific ligands Nature, 346, 818–822[CrossRef][Medline] .

10. Wilson, D.S. and Szostak, J.W. (1999) In vitro selection of functional nucleic acids Annu. Rev. Biochem., 68, 611–647[CrossRef][Web of Science][Medline] .

11. Joyce, G.F. (2004) Directed evolution of nucleic acid enzymes Annu. Rev. Biochem., 73, 791–836[CrossRef][Web of Science][Medline] .

12. Prudent, J.R., Uno, T., Schultz, P.G. (1994) Expanding the scope of RNA catalysis Science, 264, 1924–1927[Abstract/Free Full Text] .

13. Wilson, C. and Szostak, J.W. (1995) In vitro evolution of a self-alkylating ribozyme Nature, 374, 777–782[CrossRef][Medline] .

14. Conn, M.M., Prudent, J.R., Schultz, P.G. (1996) Porphyrin metalation catalyzed by a small RNA molecule J. Am. Chem. Soc., 118, 7012–7013 .

15. Wecker, M., Smith, D., Gold, L. (1996) In vitro selection of a novel catalytic RNA: characterization of a sulfur alkylation reaction and interaction with a small peptide RNA, 2, 982–994[Abstract] .

16. Zhang, B. and Cech, T.R. (1997) Peptide bond formation by in vitro selected ribozymes Nature, 390, 96–100[CrossRef][Medline] .

17. Gugliotti, L.A., Feldheim, D.L., Eaton, B.E. (2004) RNA-mediated metal–metal bond formation in the synthesis of hexagonal palladium nanoparticles Science, 304, 850–852[Abstract/Free Full Text] .

18. Serganov, A., Keiper, S., Malinina, L., Tereshko, V., Skripkin, E., Hobartner, C., Polonskaia, A., Phan, A.T., Wombacher, R., Micura, R., et al. (2005) Structural basis for Diels–Alder ribozyme-catalyzed carbon–carbon bond formation Nat. Struct. Mol. Biol., 12, 218–224[CrossRef][Web of Science][Medline] .

19. Li, Y. and Sen, D. (1996) A catalytic DNA for porphyrin metallation Nat. Struct. Biol., 3, 743–747[CrossRef][Web of Science][Medline] .

20. Travascio, P., Li, Y., Sen, D. (1998) DNA-enhanced peroxidase activity of a DNA aptamer–hemin complex Chem. Biol., 5, 505–517[CrossRef][Web of Science][Medline] .

21. Emilsson, G.M. and Breaker, R.R. (2002) Deoxyribozymes: new activities and new applications Cell. Mol. Life Sci., 59, 596–607[CrossRef][Web of Science][Medline] .

22. Lu, Y. (2002) New transition-metal-dependent DNAzymes as efficient endonucleases and as selective metal biosensors Chem. Eur. J., 8, 4589–4596 .

23. Silverman, S.K. (2004) Deoxyribozymes: DNA catalysts for bioorganic chemistry Org. Biomol. Chem., 2, 2701–2706[CrossRef][Web of Science][Medline] .

24. Achenbach, J.C., Chiuman, W., Cruz, R.P., Li, Y. (2004) DNAzymes: from creation in vitro to application in vivo Curr. Pharm. Biotechnol., 5, 321–336[CrossRef][Web of Science][Medline] .

25. Peracchi, A. (2005) DNA catalysis: potential, limitations, open questions ChemBioChem, 6, 1316–1322[CrossRef][Web of Science][Medline] .

26. Breaker, R.R. and Joyce, G.F. (1994) A DNA enzyme that cleaves RNA Chem. Biol., 1, 223–229[CrossRef][Medline] .

27. Breaker, R.R. and Joyce, G.F. (1995) A DNA enzyme with Mg²⁺-dependent RNA phosphoesterase activity Chem. Biol., 2, 655–660[CrossRef][Web of Science][Medline] .

28. Faulhammer, D. and Famulok, M. (1996) The Ca²⁺ ion as a cofactor for a novel RNA-cleaving deoxyribozyme Angew. Chem. Int. Ed. Engl., 35, 2837–2841 .

29. Santoro, S.W. and Joyce, G.F. (1997) A general purpose RNA-cleaving DNA enzyme Proc. Natl Acad. Sci. USA, 94, 4262–4266[Abstract/Free Full Text] .

30. Geyer, C.R. and Sen, D. (1997) Evidence for the metal-cofactor independence of an RNA phosphodiester-cleaving DNA enzyme Chem. Biol., 4, 579–593[CrossRef][Web of Science][Medline] .

31. Peracchi, A. (2000) Preferential activation of the 8–17 deoxyribozyme by Ca²⁺ ions. Evidence for the identity of 8–17 with the catalytic domain of the Mg5 deoxyribozyme J. Biol. Chem., 275, 11693–11697[Abstract/Free Full Text] .

32. Li, J., Zheng, W., Kwon, A.H., Lu, Y. (2000) In vitro selection and characterization of a highly efficient Zn(II)-dependent RNA-cleaving deoxyribozyme Nucleic Acids Res., 28, 481–488[Abstract/Free Full Text] .

33. Feldman, A.R. and Sen, D. (2001) A new and efficient DNA enzyme for the sequence-specific cleavage of RNA J. Mol. Biol., 313, 283–294[CrossRef][Web of Science][Medline] .

34. Mei, S.H., Liu, Z., Brennan, J.D., Li, Y. (2003) An efficient RNA-cleaving DNA enzyme that synchronizes catalysis with fluorescence signaling J. Am. Chem. Soc., 125, 412–420[CrossRef][Web of Science][Medline] .

35. Liu, Z., Mei, S.H., Brennan, J.D., Li, Y. (2003) Assemblage of signaling DNA enzymes with intriguing metal-ion specificities and pH dependences J. Am. Chem. Soc., 125, 7539–7545[CrossRef][Web of Science][Medline] .

36. Cruz, R.P.G., Withers, J.B., Li, Y. (2004) Dinucleotide junction cleavage versatility of 8–17 deoxyribozyme Chem. Biol., 11, 57–67[CrossRef][Web of Science][Medline] .

37. Perreault, D.M. and Anslyn, E.V. (1997) Unifying the current data on the mechanism of cleavage-transesterification of RNA Angew. Chem. Int. Ed. Engl., 36, 432–450 .

38. Li, Y. and Breaker, R.R. (1999) Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2'-hydroxyl group J. Am. Chem. Soc., 121, 5364–5372[CrossRef][Web of Science] .

39. Soukup, G.A. and Breaker, R.R. (1999) Relationship between internucleotide linkage geometry and the stability of RNA RNA, 5, 1308–1325[Abstract] .

40. Roth, A. and Breaker, R.R. (1998) An amino acid as a cofactor for a catalytic polynucleotide Proc. Natl Acad. Sci. USA, 95, 6027–6031[Abstract/Free Full Text] .

41. Dahm, S.C. and Uhlenbeck, O.C. (1991) Role of divalent metal ions in the hammerhead RNA cleavage reaction Biochemistry, 30, 9464–9469[CrossRef][Medline] .

42. Cech, T.R. (1987) The chemistry of self-splicing RNA and RNA enzymes Science, 236, 1532–1539[Abstract/Free Full Text] .

43. Faulhammer, D. and Famulok, M. (1997) Characterization and divalent metal-ion dependence of in vitro selected deoxyribozymes which cleave DNA/RNA chimeric oligonucleotides J. Mol. Biol., 269, 188–202[CrossRef][Web of Science][Medline] .

44. Salehi-Ashtiani, K. and Szostak, J.W. (2001) In vitro evolution suggests multiple origins for the hammerhead ribozyme Nature, 414, 82–84[CrossRef][Medline] .

45. Murray, J.B., Seyhan, A.A., Walter, N.G., Burke, J.M., Scott, W.G. (1998) The hammerhead, hairpin and VS ribozymes are catalytically proficient in monovalent cations alone Chem. Biol., 5, 587–595[CrossRef][Web of Science][Medline] .

46. Curtis, E.A. and Bartel, D.P. (2001) The hammerhead cleavage reaction in monovalent cations RNA, 7, 546–552[Abstract] .

47. O'Rear, J.L., Wang, S., Feig, A.L., Beigelman, L., Uhlenbeck, O.C., Herschlag, D. (2001) Comparison of the hammerhead cleavage reactions stimulated by monovalent and divalent cations RNA, 7, 537–545[Abstract] .

48. Carrigan, M.A., Ricardo, A., Ang, D.N., Benner, S.A. (2004) Quantitative analysis of a RNA-cleaving DNA catalyst obtained via in vitro selection Biochemistry, 43, 11446–11459[CrossRef][Medline] .

49. Flynn-Charlebois, A., Wang, Y., Prior, T.K., Rashid, I., Hoadley, K.A., Coppins, R.L., Wolf, A.C., Silverman, S.K. (2003) Deoxyribozymes with 2'-5' RNA ligase activity J. Am. Chem. Soc., 125, 2444–2454[CrossRef][Web of Science][Medline] .

50. Santoro, S.W. and Joyce, G.F. (1998) Mechanism and utility of an RNA-cleaving DNA enzyme Biochemistry, 37, 13330–13342[CrossRef][Medline] .

51. Kurreck, J., Bieber, B., Jahnel, R., Erdmann, V.A. (2002) Comparative study of DNA enzymes and ribozymes against the same full-length messenger RNA of the vanilloid receptor subtype I J. Biol. Chem., 277, 7099–7107[Abstract/Free Full Text] .

52. Pyle, A.M. (1993) Ribozymes: a distinct class of metalloenzymes Science, 261, 709–714[Abstract/Free Full Text] .

53. Yarus, M. (1993) How many catalytic RNAs? Ions and the cheshire cat conjecture. FASEB J., 7, 31–39[Abstract] .

54. Sugimoto, N., Okumoto, Y., Ohmichi, T. (1999) Effect of metal ions and sequence of deoxyribozymes on their RNA cleavage activity J. Chem. Soc. Perkin Trans., 2, 1381–1386 .

55. Ota, N., Warashina, M., Hirano, K., Hatanaka, K., Taira, K. (1998) Effects of helical structures formed by the binding arms of DNAzymes and their substrates on catalytic activity Nucleic Acids Res., 26, 3385–3391[Abstract/Free Full Text] .

56. Dahm, S.C., Derrick, W.B., Uhlenbeck, O.C. (1993) Evidence for the role of solvated metal hydroxide in the hammerhead cleavage mechanism Biochemistry, 32, 13040–13045[CrossRef][Medline] .

57. Pan, T., Dichtl, B., Uhlenbeck, O.C. (1994) Properties of an in vitro selected Pb²⁺ cleavage motif Biochemistry, 33, 9561–9565[CrossRef][Medline] .

58. Suga, H., Cowan, J.A., Szostak, J.W. (1998) Unusual metal ion catalysis in an acyl-transferase ribozyme Biochemistry, 37, 10118–10125[CrossRef][Medline] .

59. Bergman, N.H., Johnston, W.K., Bartel, D.P. (2000) Kinetic framework for ligation by an efficient RNA ligase ribozyme Biochemistry, 39, 3115–3123[CrossRef][Medline] .

60. Zaborowska, Z., Schubert, S., Kurreck, J., Erdmann, V.A. (2005) Deletion analysis in the catalytic region of the 10–23 DNA enzyme FEBS Lett., 579, 554–558[CrossRef][Web of Science][Medline] .

61. Peracchi, A., Bonaccio, M., Clerici, M. (2005) A mutational analysis of the 8–17 deoxyribozyme core J. Mol. Biol., 352, 783–794[CrossRef][Web of Science][Medline] .

62. Cairns, M.J., King, A., Sun, L.-Q. (2003) Optimisation of the 10–23 DNAzyme-substrate pairing interactions enhanced RNA cleavage activity at purine-cytosine target sites Nucleic Acids Res., 31, 2883–2889[Abstract/Free Full Text] .

63. Okumoto, Y. and Sugimoto, N. (2000) Effects of metal ions and catalytic loop sequences on the complex formation of a deoxyribozyme and its RNA substrate J. Inorg. Biochem., 82, 189–195[CrossRef][Web of Science][Medline] .

64. He, Q.C., Zhou, J.M., Zhou, D.M., Nakamatsu, Y., Baba, T., Taira, K. (2002) Comparison of metal-ion-dependent cleavages of RNA by a DNA enzyme and a hammerhead ribozyme Biomacromolecules, 3, 69–83[CrossRef][Web of Science][Medline] .

65. Cieslak, M., Szymanski, J., Adamiak, R.W., Cierniewski, C.S. (2003) Structural rearrangements of the 10–23 DNAzyme to beta 3 integrin subunit mRNA induced by cations and their relations to the catalytic activity J. Biol. Chem., 278, 47987–47996[Abstract/Free Full Text] .

66. Liu, J. and Lu, Y. (2002) FRET study of a trifluorophore-labeled DNAzyme J. Am. Chem. Soc., 124, 15208–15216[CrossRef][Web of Science][Medline] .

67. Brown, A.K., Li, J., Pavot, C.M., Lu, Y. (2003) A lead-dependent DNAzyme with a two-step mechanism Biochemistry, 42, 7152–7161[CrossRef][Medline] .

68. Bonaccio, M., Credali, A., Peracchi, A. (2004) Kinetic and thermodynamic characterization of the RNA-cleaving 8–17 deoxyribozyme Nucleic Acids Res., 32, 916–925[Abstract/Free Full Text] .

69. Geyer, C.R. and Sen, D. (1998) Lanthanide probes for a phosphodiester-cleaving, lead-dependent, DNAzyme J. Mol. Biol., 275, 483–489[CrossRef][Web of Science][Medline] .

70. Nowakowski, J., Shim, P.J., Joyce, G.F., Stout, C.D. (1999) Crystallization of the 10–23 DNA enzyme using a combinatorial screen of paired oligonucleotides Acta Crystallogr. D. Biol. Crystallogr., D55, 1885–1892[CrossRef][Medline] .

71. Nowakowski, J., Shim, P.J., Prasad, G.S., Stout, C.D., Joyce, G.F. (1999) Crystal structure of an 82-nucleotide RNA–DNA complex formed by the 10–23 DNA enzyme Nat. Struct. Biol., 6, 151–156[Medline] .

72. Pyle, A.M., Chu, V.T., Jankowsky, E., Boudvillain, M. (2000) Using DNAzymes to cut, process, and map RNA molecules for structural studies or modification Methods Enzymol., 317, 140–146[CrossRef][Web of Science][Medline] .

73. Cheong, H.K., Hwang, E., Lee, C., Choi, B.S., Cheong, C. (2004) Rapid preparation of RNA samples for NMR spectroscopy and X-ray crystallography Nucleic Acids Res., 32, e84[Abstract/Free Full Text] .

74. Konforti, B.B., Liu, Q., Pyle, A.M. (1998) A map of the binding site for catalytic domain 5 in the core of a group II intron ribozyme EMBO J., 17, 7105–7117[CrossRef][Web of Science][Medline] .

75. Rhode, B.M., Hartmuth, K., Urlaub, H., Luhrmann, R. (2003) Analysis of site-specific protein–RNA cross-links in isolated RNP complexes, combining affinity selection and mass spectrometry RNA, 9, 1542–1551[Abstract/Free Full Text] .

76. Coleman, T.M., Wang, G., Huang, F. (2004) Superior 5' homogeneity of RNA from ATP-initiated transcription under the T7 2.5 promoter Nucleic Acids Res., 32, e14[Abstract/Free Full Text] .

77. Wang, Y. and Silverman, S.K. (2005) Directing the outcome of deoxyribozyme selections to favor native 3'–5' RNA ligation Biochemistry, 44, 3017–3023[CrossRef][Medline] .

78. Purtha, W.E., Coppins, R.L., Smalley, M.K., Silverman, S.K. (2005) General deoxyribozyme-catalyzed synthesis of native 3'–5' RNA Linkages J. Am. Chem. Soc., 127, 13124–13125[CrossRef][Web of Science][Medline] .

79. Sugimoto, N., Nakano, S., Katoh, M., Matsumura, A., Nakamuta, H., Ohmichi, T., Yoneyama, M., Sasaki, M. (1995) Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes Biochemistry, 34, 11211–11216[CrossRef][Medline] .

80. Schubert, S., Furste, J.P., Werk, D., Grunert, H.P., Zeichhardt, H., Erdmann, V.A., Kurreck, J. (2004) Gaining target access for deoxyribozymes J. Mol. Biol., 339, 355–363[CrossRef][Web of Science][Medline] .

81. Vester, B., Lundberg, L.B., Sorensen, M.D., Babu, B.R., Douthwaite, S., Wengel, J. (2004) Improved RNA cleavage by LNAzyme derivatives of DNAzymes Biochem. Soc. Trans., 32, 37–40[CrossRef][Web of Science][Medline] .

82. Kierzek, E., Ciesielska, A., Pasternak, K., Mathews, D.H., Turner, D.H., Kierzek, R. (2005) The influence of locked nucleic acid residues on the thermodynamic properties of 2'-O-methyl RNA/RNA heteroduplexes Nucleic Acids Res., 33, 5082–5093[Abstract/Free Full Text] .

83. Joyce, G.F. (2001) RNA cleavage by the 10–23 DNA enzyme Methods Enzymol., 341, 503–517[Web of Science][Medline] .

84. Khachigian, L.M. (2002) DNAzymes: cutting a path to a new class of therapeutics Curr. Opin. Mol. Ther., 4, 119–121[Web of Science][Medline] .

85. Schubert, S. and Kurreck, J. (2004) Ribozyme- and deoxyribozyme-strategies for medical applications Curr. Drug Targets, 5, 667–681[CrossRef][Web of Science][Medline] .

86. Sun, L.Q., Cairns, M.J., Saravolac, E.G., Baker, A., Gerlach, W.L. (2000) Catalytic nucleic acids: from lab to applications Pharmacol. Rev., 52, 325–347[Abstract/Free Full Text] .

87. Cairns, M.J., Saravolac, E.G., Sun, L.Q. (2002) Catalytic DNA: a novel tool for gene suppression Curr. Drug Targets, 3, 269–279[CrossRef][Web of Science][Medline] .

88. Steele, D., Kertsburg, A., Soukup, G.A. (2003) Engineered catalytic RNA and DNA: new biochemical tools for drug discovery and design Am. J. Pharmacogenomics, 3, 131–144[CrossRef][Medline] .

89. Trulzsch, B. and Wood, M. (2004) Applications of nucleic acid technology in the CNS J. Neurochem., 88, 257–265[Web of Science][Medline] .

90. Wu, Y., Yu, L., McMahon, R., Rossi, J.J., Forman, S.J., Snyder, D.S. (1999) Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes) Hum. Gene Ther., 10, 2847–2857[CrossRef][Web of Science][Medline] .

91. Yen, L., Strittmatter, S.M., Kalb, R.G. (1999) Sequence-specific cleavage of Huntingtin mRNA by catalytic DNA Ann. Neurol., 46, 366–373[CrossRef][Web of Science][Medline] .

92. Cairns, M.J., Hopkins, T.M., Witherington, C., Wang, L., Sun, L.-Q. (1999) Target site selection for an RNA-cleaving catalytic DNA Nat. Biotechnol., 17, 480–486[CrossRef][Web of Science][Medline] .

93. Unwalla, H. and Banerjea, A.C. (2001) Novel mono- and di-DNA-enzymes targeted to cleave TAT or TAT-REV RNA inhibit HIV-1 gene expression Antiviral Res., 51, 127–139[CrossRef][Web of Science][Medline] .

94. Zhang, L., Gasper, W.J., Stass, S.A., Ioffe, O.B., Davis, M.A., Mixson, A.J. (2002) Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor 2 Cancer Res., 62, 5463–5469[Abstract/Free Full Text] .

95. Hjiantoniou, E., Iseki, S., Uney, J.B., Phylactou, L.A. (2003) DNazyme-mediated cleavage of Twist transcripts and increase in cellular apoptosis Biochem. Biophys. Res. Commun., 300, 178–181[CrossRef][Web of Science][Medline] .

96. Mitchell, A., Dass, C.R., Sun, L.-Q., Khachigian, L.M. (2004) Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1 Nucleic Acids Res., 32, 3065–3069[Abstract/Free Full Text] .

97. Xiang, G., Schuster, M.D., Seki, T., Kocher, A.A., Eshghi, S., Boyle, A., Itescu, S. (2004) Down-regulation of plasminogen activator inhibitor 1 expression promotes myocardial neovascularization by bone marrow progenitors J. Exp. Med., 200, 1657–1666[Abstract/Free Full Text] .

98. Kabuli, M., Yin, J.A., Tobal, K. (2004) Targeting PML/RARalpha transcript with DNAzymes results in reduction of proliferation and induction of apoptosis in APL cells Hematol. J., 5, 426–433[CrossRef][Medline] .

99. Ackermann, J.M., Kanugula, S., Pegg, A.E. (2005) DNAzyme-mediated silencing of ornithine decarboxylase Biochemistry, 44, 2143–2152[CrossRef][Medline] .

100. Sioud, M. (2001) Nucleic acid enzymes as a novel generation of anti-gene agents Curr. Mol. Med., 1, 575–588[CrossRef][Medline] .

101. Opalinska, J.B. and Gewirtz, A.M. (2002) Nucleic-acid therapeutics: basic principles and recent applications Nat. Rev. Drug Discov., 1, 503–514[CrossRef][Web of Science][Medline] .

102. Achenbach, T.V., Brunner, B., Heermeier, K. (2003) Oligonucleotide-based knockdown technologies: antisense versus RNA interference ChemBioChem, 4, 928–935[CrossRef][Web of Science][Medline] .

103. Sioud, M. (2004) Ribozyme- and siRNA-mediated mRNA degradation: a general introduction Methods Mol. Biol., 252, 1–8[Medline] .

104. Chen, Y., Ji, Y.J., Roxby, R., Conrad, C. (2000) In vivo expression of single-stranded DNA in mammalian cells with DNA enzyme sequences targeted to C-raf Antisense Nucleic Acid Drug Dev., 10, 415–422[Web of Science][Medline] .

105. Datta, H.J. and Glazer, P.M. (2001) Intracellular generation of single-stranded DNA for chromosomal triplex formation and induced recombination Nucleic Acids Res., 29, 5140–5147[Abstract/Free Full Text] .

106. Chen, Y., Ji, Y.J., Conrad, C. (2003) Expression of ssDNA in mammalian cells BioTechniques, 34, 167–171[Web of Science][Medline] .

107. Chen, Y. and McMicken, H.W. (2003) Intracellular production of DNA enzyme by a novel single-stranded DNA expression vector Gene Ther., 10, 1776–1780[CrossRef][Web of Science][Medline] .

108. Tan, X.-X., Rose, K., Margolin, W., Chen, Y. (2004) DNA enzyme generated by a novel single-stranded DNA expression vector inhibits expression of the essential bacterial cell division gene ftsZ Biochemistry, 43, 1111–1117[Medline] .

109. Chen, F., Wang, R., Li, Z., Liu, B., Wang, X., Sun, Y., Hao, D., Zhang, J. (2004) A novel replicating circular DNAzyme Nucleic Acids Res., 32, 2336–2341[Abstract/Free Full Text] .

110. Nunamaker, E.A., Zhang, H.Y., Shirasawa, Y., Benoit, J.N., Dean, D.A. (2003) Electroporation-mediated delivery of catalytic oligodeoxynucleotides for manipulation of vascular gene expression Am. J. Physiol. Heart Circ. Physiol., 285, H2240–H2247[Abstract/Free Full Text] .

111. Pun, S.H., Tack, F., Bellocq, N.C., Cheng, J., Grubbs, B.H., Jensen, G.S., Davis, M.E., Brewster, M., Janicot, M., Janssens, B., et al. (2004) Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles Cancer Biol. Ther., 3, 641–650[Web of Science][Medline] .

112. Fahmy, R.G. and Khachigian, L.M. (2004) Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth Nucleic Acids Res., 32, 2281–2285[Abstract/Free Full Text] .

113. Kubo, T., Takamori, K., Kanno, K., Rumiana, B., Ohba, H., Matsukisono, M., Akebiyama, Y., Fujii, M. (2005) Efficient cleavage of RNA, enhanced cellular uptake, and controlled intracellular localization of conjugate DNAzymes Bioorg. Med. Chem. Lett., 15, 167–170[CrossRef][Medline] .

114. Dass, C.R., Saravolac, E.G., Li, Y., Sun, L.-Q. (2002) Cellular uptake, distribution, and stability of 10–23 deoxyribozymes Antisense Nucleic Acid Drug Dev., 12, 289–299[CrossRef][Web of Science][Medline] .

115. Takahashi, H., Hamazaki, H., Habu, Y., Hayashi, M., Abe, T., Miyano-Kurosaki, N., Takaku, H. (2004) A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells FEBS Lett., 560, 69–74[CrossRef][Web of Science][Medline] .

116. Schubert, S., Gul, D.C., Grunert, H.P., Zeichhardt, H., Erdmann, V.A., Kurreck, J. (2003) RNA cleaving ‘10–23’ DNAzymes with enhanced stability and activity Nucleic Acids Res., 31, 5982–5992[Abstract/Free Full Text] .

117. Pan, W.H., Devlin, H.F., Kelley, C., Isom, H.C., Clawson, G.A. (2001) A selection system for identifying accessible sites in target RNAs RNA, 7, 610–621[Abstract] .

118. Sriram, B. and Banerjea, A.C. (2000) In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression Biochem. J., 352, 667–673[Medline] .

119. Köhler, U., Ayre, B.G., Goodman, H.M., Haseloff, J. (1999) Trans-splicing ribozymes for targeted gene delivery J. Mol. Biol., 285, 1935–1950[CrossRef][Web of Science][Medline] .

120. Watanabe, T. and Sullenger, B.A. (2000) RNA repair: a novel approach to gene therapy Adv. Drug Deliv. Rev., 44, 109–118[CrossRef][Web of Science][Medline] .

121. Phylactou, L.A. (2000) Ribozyme and peptide-nucleic acid-based gene therapy Adv. Drug Deliv. Rev., 44, 97–108[CrossRef][Web of Science][Medline] .

122. Bell, M.A., Johnson, A.K., Testa, S.M. (2002) Ribozyme-catalyzed excision of targeted sequences from within RNAs Biochemistry, 41, 15327–15333[CrossRef][Medline] .

123. Johnson, A.K., Sinha, J., Testa, S.M. (2005) Trans insertion-splicing: ribozyme-catalyzed insertion of targeted sequences into RNAs Biochemistry, 44, 10702–10710[CrossRef][Medline] .

124. Li, J., Zheng, W., Kwon, A.H., Lu, Y. (2000) A highly sensitive and selective catalytic DNA biosensor for lead ions J. Am. Chem. Soc., 122, 10466–10467 .

125. Liu, J. and Lu, Y. (2003) Improving fluorescent DNAzyme biosensors by combining inter- and intramolecular quenchers Anal. Chem., 75, 6666–6672[Medline] .

126. Liu, J. and Lu, Y. (2004) Accelerated color change of gold nanoparticles assembled by DNAzymes for simple and fast colorimetric Pb²⁺ detection J. Am. Chem. Soc., 126, 12298–12305[CrossRef][Web of Science][Medline] .

127. Swearingen, C.B., Wernette, D.P., Cropek, D.M., Lu, Y., Sweedler, J.V., Bohn, P.W. (2005) Immobilization of a catalytic DNA molecular beacon on Au for Pb(II) detection Anal. Chem., 77, 442–448[Medline] .

128. Liu, J. and Lu, Y. (2003) A colorimetric lead biosensor using DNAzyme-directed assembly of gold nanoparticles J. Am. Chem. Soc., 125, 6642–6643[CrossRef][Web of Science][Medline] .

129. Liu, J. and Lu, Y. (2004) Adenosine-dependent assembly of aptazyme-functionalized gold nanoparticles and its application as a colorimetric biosensor Anal. Chem., 76, 1627–1632[Medline] .

130. Wang, D.Y. and Sen, D. (2001) A novel mode of regulation of an RNA-cleaving DNAzyme by effectors that bind to both enzyme and substrate J. Mol. Biol., 310, 723–734[CrossRef][Web of Science][Medline] .

131. Wang, D.Y., Lai, B.H., Feldman, A.R., Sen, D. (2002) A general approach for the use of oligonucleotide effectors to regulate the catalysis of RNA-cleaving ribozymes and DNAzymes Nucleic Acids Res., 30, 1735–1742[Abstract/Free Full Text] .

132. Wang, D.Y., Lai, B.H., Sen, D. (2002) A general strategy for effector-mediated control of RNA-cleaving ribozymes and DNA enzymes J. Mol. Biol., 318, 33–43[CrossRef][Web of Science][Medline] .

133. Lu, Y., Liu, J., Li, J., Bruesehoff, P.J., Pavot, C.M., Brown, A.K. (2003) New highly sensitive and selective catalytic DNA biosensors for metal ions Biosens. Bioelectron., 18, 529–540[CrossRef][Web of Science][Medline] .

134. Liu, J. and Lu, Y. (2004) Optimization of a Pb²⁺-directed gold nanoparticle/DNAzyme assembly and its application as a colorimetric biosensor for Pb²⁺ Chem. Mater., 16, 3231–3238[CrossRef] .

135. Liu, J. and Lu, Y. (2005) Stimuli-responsive disassembly of nanoparticle aggregates for light-up colorimetric sensing J. Am. Chem. Soc., 127, 12677–12683[CrossRef][Web of Science][Medline] .

136. Shen, Y., Brennan, J.D., Li, Y. (2005) Characterizing the secondary structure and identifying functionally essential nucleotides of pH6DZ1, a fluorescence-signaling and RNA-cleaving deoxyribozyme Biochemistry, 44, 5328–5335[CrossRef][Medline] .

137. Nutiu, R. and Li, Y. (2004) Structure-switching signaling aptamers: transducing molecular recognition into fluorescence signaling Chem. Eur. J., 10, 1868–1876[CrossRef] .

138. Achenbach, J.C., Nutiu, R., Li, Y. (2005) Structure-switching allosteric deoxyribozymes Anal. Chim. Acta, 534, 41–51 .

139. Stojanovic, M.N., de Prada, P., Landry, D.W. (2000) Homogeneous assays based on deoxyribozyme catalysis Nucleic Acids Res., 28, 2915–2918[Abstract/Free Full Text] .

140. Silverman, S.K. (2004) Practical and general synthesis of 5'-adenylated RNA (5'-AppRNA) RNA, 10, 731–746[Abstract/Free Full Text] .

141. Hiley, S.L., Sood, V.D., Fan, J., Collins, R.A. (2002) 4-thio-U cross-linking identifies the active site of the VS ribozyme EMBO J., 21, 4691–4698[CrossRef][Web of Science][Medline] .

142. Chu, V.T., Liu, Q., Podar, M., Perlman, P.S., Pyle, A.M. (1998) More than one way to splice an RNA: branching without a bulge and splicing without branching in group II introns RNA, 4, 1186–1202[Abstract] .

143. Chu, V.T., Adamidi, C., Liu, Q., Perlman, P.S., Pyle, A.M. (2001) Control of branch-site choice by a group II intron EMBO J., 20, 6866–6876[CrossRef][Web of Science][Medline] .

144. Okumoto, Y., Ohmichi, T., Sugimoto, N. (2002) Immobilized small deoxyribozyme to distinguish RNA secondary structures Biochemistry, 41, 2769–2773[CrossRef][Medline] .

145. Todd, A.V., Fuery, C.J., Impey, H.L., Applegate, T.L., Haughton, M.A. (2000) DzyNA-PCR: use of DNAzymes to detect and quantify nucleic acid sequences in a real-time fluorescent format Clin. Chem., 46, 625–630[Abstract/Free Full Text] .

146. Cairns, M.J., King, A., Sun, L.-Q. (2000) Nucleic acid mutation analysis using catalytic DNA Nucleic Acids Res., 28, E9[Medline] .

147. Suenaga, H., Liu, R., Shiramasa, Y., Kanagawa, T. (2005) Novel approach to quantitative detection of specific rRNA in a microbial community, using catalytic DNA Appl. Environ. Microbiol., 71, 4879–4884[Abstract/Free Full Text] .

148. Stojanovic, M.N., Semova, S., Kolpashchikov, D., Macdonald, J., Morgan, C., Stefanovic, D. (2005) Deoxyribozyme-based ligase logic gates and their initial circuits J. Am. Chem. Soc., 127, 6914–6915[CrossRef][Web of Science][Medline] .

149. Stojanovic, M.N. and Stefanovic, D. (2003) A deoxyribozyme-based molecular automaton Nat. Biotechnol., 21, 1069–1074[CrossRef][Web of Science][Medline] .

150. Stojanovic, M.N. and Stefanovic, D. (2003) Deoxyribozyme-based half-adder J. Am. Chem. Soc., 125, 6673–6676[CrossRef][Web of Science][Medline] .

151. Stojanovic, M.N., Mitchell, T.E., Stefanovic, D. (2002) Deoxyribozyme-based logic gates J. Am. Chem. Soc., 124, 3555–3561[CrossRef][Web of Science][Medline] .

152. Chen, Y., Wang, M., Mao, C. (2004) An autonomous DNA nanomotor powered by a DNA enzyme Angew. Chem. Int. Ed., 43, 3554–3557[CrossRef] .

153. Ordoukhanian, P. and Joyce, G.F. (2002) RNA-cleaving DNA enzymes with altered regio- or enantioselectivity J. Am. Chem. Soc., 124, 12499–12506[CrossRef][Web of Science][Medline] .

154. Santoro, S.W., Joyce, G.F., Sakthivel, K., Gramatikova, S., Barbas, C.F., III. (2000) RNA cleavage by a DNA enzyme with extended chemical functionality J. Am. Chem. Soc., 122, 2433–2439[CrossRef][Web of Science][Medline] .

155. Perrin, D.M., Garestier, T., Hélène, C. (2001) Bridging the gap between proteins and nucleic acids: a metal-independent RNAseA mimic with two protein-like functionalities J. Am. Chem. Soc., 123, 1556–1563[CrossRef][Web of Science][Medline] .

156. Sidorov, A.V., Grasby, J.A., Williams, D.M. (2004) Sequence-specific cleavage of RNA in the absence of divalent metal ions by a DNAzyme incorporating imidazolyl and amino functionalities Nucleic Acids Res., 32, 1591–1601[Abstract/Free Full Text] .

157. Lermer, L., Roupioz, Y., Ting, R., Perrin, D.M. (2002) Toward an RNaseA mimic: A DNAzyme with imidazoles and cationic amines J. Am. Chem. Soc., 124, 9960–9961[CrossRef][Web of Science][Medline] .

158. Ohbayashi, T., Kuwahara, M., Hasegawa, M., Kasamatsu, T., Tamura, T., Sawai, H. (2005) Expansion of repertoire of modified DNAs prepared by PCR using KOD Dash DNA polymerase Org. Biomol. Chem., 3, 2463–2468[CrossRef][Web of Science][Medline] .

159. Ting, R., Lermer, L., Perrin, D.M. (2004) Triggering DNAzymes with light: a photoactive C8 thioether-linked adenosine J. Am. Chem. Soc., 126, 12720–12721[Web of Science][Medline] .

160. Liu, Y. and Sen, D. (2004) Light-regulated catalysis by an RNA-cleaving deoxyribozyme J. Mol. Biol., 341, 887–892[CrossRef][Web of Science][Medline] .

161. Beaudry, A., DeFoe, J., Zinnen, S., Burgin, A., Beigelman, L. (2000) In vitro selection of a novel nuclease-resistant RNA phosphodiesterase Chem. Biol., 7, 323–334[CrossRef][Web of Science][Medline] .

162. Hoadley, K.A., Purtha, W.E., Wolf, A.C., Flynn-Charlebois, A., Silverman, S.K. (2005) Zn²⁺-dependent deoxyribozymes that form natural and unnatural RNA linkages Biochemistry, 44, 9217–9231[CrossRef][Medline] .

163. Wang, Y. and Silverman, S.K. (2005) Efficient one-step synthesis of biologically related lariat RNAs by a deoxyribozyme Angew. Chem. Int. Ed., 44, 5863–5866[CrossRef] .

164. Seetharaman, S., Zivarts, M., Sudarsan, N., Breaker, R.R. (2001) Immobilized RNA switches for the analysis of complex chemical and biological mixtures Nat. Biotechnol., 19, 336–341[CrossRef][Web of Science][Medline] .

165. Ismagilov, R.F. (2003) Integrated microfluidic systems Angew. Chem. Int. Ed., 42, 4130–4132[CrossRef] .

CiteULike    Connotea    Del.icio.us    What's this?

This article has been cited by other articles:

				K. Schlosser, J. Gu, J. C. F. Lam, and Y. Li In vitro selection of small RNA-cleaving deoxyribozymes that cleave pyrimidine-pyrimidine junctions Nucleic Acids Res., August 1, 2008; 36(14): 4768 - 4777. [Abstract] [Full Text] [PDF]

				S. Roy, N. Gupta, N. Subramanian, T. Mondal, A. C. Banerjea, and S. Das Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication J. Gen. Virol., July 1, 2008; 89(7): 1579 - 1586. [Abstract] [Full Text] [PDF]

				C. R. Dass, P. F.M. Choong, and L. M. Khachigian DNAzyme technology and cancer therapy: cleave and let die Mol. Cancer Ther., February 1, 2008; 7(2): 243 - 251. [Abstract] [Full Text] [PDF]

				M. Hengesbach, M. Meusburger, F. Lyko, and M. Helm Use of DNAzymes for site-specific analysis of ribonucleotide modifications RNA, January 1, 2008; 14(1): 180 - 187. [Abstract] [Full Text] [PDF]

				S. Donini, M. Clerici, J. Wengel, B. Vester, and A. Peracchi The Advantages of Being Locked: ASSESSING THE CLEAVAGE OF SHORT AND LONG RNAs BY LOCKED NUCLEIC ACID-CONTAINING 8 17 DEOXYRIBOZYMES J. Biol. Chem., December 7, 2007; 282(49): 35510 - 35518. [Abstract] [Full Text] [PDF]

				W. Chiuman and Y. Li Efficient signaling platforms built from a small catalytic DNA and doubly labeled fluorogenic substrates Nucleic Acids Res., January 28, 2007; 35(2): 401 - 405. [Abstract] [Full Text] [PDF]

This Article Abstract Print PDF (1077K) Screen PDF (406K) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Commercial Re-use Guidelines for Open Access NAR Content Google Scholar Articles by Silverman, S. K. Search for Related Content PubMed PubMed Citation Articles by Silverman, S. K. Social Bookmarking          What's this?

Online ISSN 1362-4962 - Print ISSN 0305-1048

Copyright © 2009 Oxford University Press

Oxford Journals Oxford University Press

• Site Map
• Privacy Policy
• Frequently Asked Questions

Other Oxford University Press sites: Oxford University Press Oxford Journals China Oxford Journals Japan American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics